Glycoside constituents of Camellia amplexicaulis and their α-glucosidase inhibitory activity

Nat Prod Res. 2024 Feb-Mar;38(5):759-767. doi: 10.1080/14786419.2023.2196724. Epub 2023 Apr 2.

Abstract

Four new glycosides, named amplexicosides A-D (1-4), and five known compounds: benzyl 2-[β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyloxy]-benzoate (5), benzyl 2-neohesperidosyloxy-6-hydroxybenzoate (6), chrysandroside A (7), chrysandroside B (8) and camelliquercetiside C (9) were isolated from the branches and leaves of Camellia amplexicaulis (Pit.) Cohen-Stuart. Their structures were elucidated using HR-ESI-MS and 1D- and 2D-NMR spectra and compared to reported NMR data. All of the isolated compounds were screened in an α-glucosidase assay. Compounds 4, 8, and 9 significantly inhibited α-glucosidase with respective IC50 values of 254.9 ± 4.2, 304.8 ± 11.9 and 228.1 ± 16.4 μM.

Keywords: Camellia amplexicaulis; amplexicoside; benzoate derivative; flavonol glycoside; α-glucosidase inhibitor.

MeSH terms

  • Camellia*
  • Cardiac Glycosides*
  • Glycoside Hydrolase Inhibitors / chemistry
  • Glycoside Hydrolase Inhibitors / pharmacology
  • Glycosides / chemistry
  • Glycosides / pharmacology
  • Molecular Structure
  • alpha-Glucosidases

Substances

  • Glycosides
  • alpha-Glucosidases
  • Glycoside Hydrolase Inhibitors
  • Cardiac Glycosides